Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/eci.13326 http://scihub22266oqcxt.onion/10.1111/eci.13326 32562550!7323159!32562550     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Clin+Invest 2020 ; 50 (7): e13326 Nephropedia Template TP {{tp|p=32562550|t=2020. COVID-19: Some clinical questions after the first 4 months |pdf=|usr=}}{{32562550}} gab.com Text COVID-19: Some clinical questions after the first 4 months JO: Eur J Clin Invest http://www.kidney.de/pget.php?&tw=1&pmid=32562550 #FOAvip ä Twit Text FOAVip COVID-19: Some clinical questions after the first 4 months ????Eur J Clin Invest http://www.kidney.de/pget.php?&tw=1&pmid=32562550 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32562550 #FOAvip English Wikipedia <ref>{{Cite pmid|32562550}}</ref> COVID-19: Some clinical questions after the first 4 months #MMPMID32562550 Bassetti M; Ansaldi F; Icardi G; Pelosi P; Robba C; Taramasso L; Trucchi C; Vena A; Giacobbe DR Eur J Clin Invest 2020[Jul]; 50 (7): e13326 PMID32562550show ga ä |Age Factors[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Vaccines[MESH] |Comorbidity[MESH] |Coronavirus Infections/*drug therapy/immunology/prevention & control[MESH] |Cytokine Release Syndrome/*drug therapy/immunology[MESH] |Genetic Predisposition to Disease[MESH] |Humans[MESH] |Lymphohistiocytosis, Hemophagocytic/immunology[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*drug therapy/immunology/prevention & control[MESH] |Prognosis[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Sex Factors[MESH] |Superinfection/epidemiology[MESH]COVID-19: Some clinical questions after the first 4 months (epmc).pdf DeepDyve Pubget Overpricing